120 related articles for article (PubMed ID: 37219008)
1. Phosphorylation of Bcl-2 by JNK confers gemcitabine resistance in lung cancer cells by reducing autophagy-mediated cell death.
Chiu CH; Ramesh S; Liao PH; Kuo WW; Chen MC; Kuo CH; Li CC; Wang TF; Lin YM; Lin YJ; Huang CY
Environ Toxicol; 2023 Sep; 38(9):2121-2131. PubMed ID: 37219008
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine resistance in non-small cell lung cancer is mediated through activation of the PI3K/AKT/NF-κB pathway and suppression of ERK signaling by reactive oxygen species.
Chiu CH; Lin YJ; Ramesh S; Kuo WW; Chen MC; Kuo CH; Li CC; Wang TF; Lin YM; Liao PH; Huang CY
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23497. PubMed ID: 37564025
[TBL] [Abstract][Full Text] [Related]
3. TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy.
Ye X; Xie G; Liu Z; Tang J; Cui M; Wang C; Guo C; Tang J
Med Sci Monit; 2020 Sep; 26():e922703. PubMed ID: 32946432
[TBL] [Abstract][Full Text] [Related]
4. The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity.
Oguri T; Achiwa H; Sato S; Bessho Y; Takano Y; Miyazaki M; Muramatsu H; Maeda H; Niimi T; Ueda R
Mol Cancer Ther; 2006 Jul; 5(7):1800-6. PubMed ID: 16891466
[TBL] [Abstract][Full Text] [Related]
5. Artemisia argyi extract induces apoptosis in human gemcitabine-resistant lung cancer cells via the PI3K/MAPK signaling pathway.
Su SH; Sundhar N; Kuo WW; Lai SC; Kuo CH; Ho TJ; Lin PY; Lin SZ; Shih CY; Lin YJ; Huang CY
J Ethnopharmacol; 2022 Dec; 299():115658. PubMed ID: 36075273
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin C treatment induces resistance and enhanced migration via phosphorylated Akt in aggressive lung cancer cells.
Shen CY; Chen LH; Lin YF; Lai LC; Chuang EY; Tsai MH
Oncotarget; 2016 Nov; 7(48):79995-80007. PubMed ID: 27833080
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).
Mani J; Vallo S; Rakel S; Antonietti P; Gessler F; Blaheta R; Bartsch G; Michaelis M; Cinatl J; Haferkamp A; Kögel D
BMC Cancer; 2015 Apr; 15():224. PubMed ID: 25885284
[TBL] [Abstract][Full Text] [Related]
8. High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells.
Wang TH; Chen CC; Huang KY; Shih YM; Chen CY
Phytomedicine; 2019 Nov; 64():152926. PubMed ID: 31454652
[TBL] [Abstract][Full Text] [Related]
9. Microwave hyperthermia enhances the sensitivity of lung cancer cells to gemcitabine through reactive oxygen species‑induced autophagic death.
Yang Y; Yang CL; Zhao ZJ; Zuo XX; Liang TS; Yang Y; Ma SL; Yang DK
Oncol Rep; 2019 May; 41(5):3100-3110. PubMed ID: 30976815
[TBL] [Abstract][Full Text] [Related]
10. Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells.
Huang XL; Zhang H; Yang XY; Dong XY; Xie XY; Yin HB; Gou X; Lin Y; He WY
Anticancer Drugs; 2017 Jul; 28(6):596-602. PubMed ID: 28430744
[TBL] [Abstract][Full Text] [Related]
11. MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p/PBOV1 axis.
Chen W; Tan X; Yang Q; Fang Z; Xu Y
Cell Signal; 2022 Jun; 94():110326. PubMed ID: 35367362
[TBL] [Abstract][Full Text] [Related]
12. FOXO3/TRIM22 axis abated the antitumor effect of gemcitabine in non-small cell lung cancer via autophagy induction.
Wang Y; Liang HX; Zhang CM; Zou M; Zou BB; Wei W; Hu W
Transl Cancer Res; 2020 Feb; 9(2):937-948. PubMed ID: 35117439
[TBL] [Abstract][Full Text] [Related]
13. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer.
Hatami E; Nagesh PKB; Jaggi M; Chauhan SC; Yallapu MM
Eur J Pharmacol; 2020 Dec; 888():173486. PubMed ID: 32805254
[TBL] [Abstract][Full Text] [Related]
14. GPR78 Regulates Autophagy and Drug Resistance in Non-small Cell Lung Cancer.
Liao X; Cai R; Li G; Chen F
Altern Ther Health Med; 2023 Jan; 29(1):130-136. PubMed ID: 35986740
[TBL] [Abstract][Full Text] [Related]
15. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
[TBL] [Abstract][Full Text] [Related]
16. Antihelminthic Niclosamide Induces Autophagy and Delayed Apoptosis in Human Non-small Lung Cancer Cells
Chai WH; Li YR; Lin SH; Chao YH; Chen CH; Chan PC; Lin CH
Anticancer Res; 2020 Mar; 40(3):1405-1417. PubMed ID: 32132037
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine-Induced Autophagy Protects Human Lung Cancer Cells from Apoptotic Death.
Wu HM; Shao LJ; Jiang ZF; Liu RY
Lung; 2016 Dec; 194(6):959-966. PubMed ID: 27604425
[TBL] [Abstract][Full Text] [Related]
18. Jervine inhibits non-small cell lung cancer (NSCLC) progression by suppressing Hedgehog and AKT signaling via triggering autophagy-regulated apoptosis.
Lei W; Huo Z
Biochem Biophys Res Commun; 2020 Dec; 533(3):397-403. PubMed ID: 32972750
[TBL] [Abstract][Full Text] [Related]
19. Pyoluteorin Induces Apoptosis and Autophagy in NSCLC Cells.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):976-983. PubMed ID: 34193693
[TBL] [Abstract][Full Text] [Related]
20. [Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines].
Liu XQ; Wang WX; Lin L; Song ST
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):17-21. PubMed ID: 20211060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
